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Peptide Induce Membrane Fusion:
Peptide Structure Required for the Fusion
Sho Takahashi, Ryo Ishiguro, and Tomoharu Matsumoto
Amphiphilic a'-helical peptides may induce biomembrane fusion. Measurements of fusion activity of about 80
peptides having modified amino acid sequences of influenza hemagglutinin HA-2 subunit N-terminal domain
revealed that, in addition to amphiphilic properties, intermittent distribution of bulky hydrophobic residues is
crucial for peptides to be active in triggering membrane fusion.
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The subdivision of Biopolymer Structure has two
activities: Physicochemical studies of synthetic peptides as
a model of protein structure in the aspects of stability of
secondary or super secondary structures and function,
and elucidation of protein structures by X-ray
crystallography. This year, we will focus on the recent
results in the former activity, mainly a structure formation
of small peptides in biomembranes and a peptide function
to induce lipid membrane fusion.
Phospholipid bilayers consist of a basic structure in
living organisms. They form not only a cell wall to
segregate a living system from the environment, also
intracellular vesicles called organelles such as nucleus,
mitochondrion, Golgi apparatus, endosome, etc., each of
which takes a specific action in a living cell. As a cell is
encapsulated by cell wall, incorporation or secretion of
substances (except small molecules) into or from a cell
requires a specific mechanism to pass through the
membrane. A Golgi system and endosome are
responsible for these processes. For example, infection
of enveloped viruses, a release of viral genomes in
cytoplasm, takes place either by direct fusion of a viral
envelope with cell membrane or by fusion of viral
membrane with endosomal one after incorporation of
viral particles in an endosome (endocytosis). The
influenza virus infects a living cell by an endocytic
pathway. The viral envelope fuses to an endosome
membrane when pH inside the organelle was lowered
below 5.5 in the process of endocytosis. A specific
protein, hemagglutinin, was identified to be responsible
to trigger the fusion at acidic pH, while it is inactive at
neutral. Hemagglutinin is a multifunctional protein
embedded in a viral envelope' and its subunit HA-2 has a
stretch of hydrophobic amino acids as an N-terminal
segment, which had been called putative fusion peptide.
We found that a synthetic 20-residue peptide having the
same amino acid sequence as that of influenza virus strain
AlPRIS/34 (H-1) could induce lipid vesicle fusion with the
similar dependency on pH [1]. Several aspects have
been revealed: (1) the peptides that cause membrane
fusion must interact with lipid membranes and have an
amphiphilic nature by forming ordered secondary
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(1) Peptide secondary or supersecondary structures in aqueous or hydrophobic environments are studied to get a
principle of protein architecture, employing various spectroscopic methods. (2) Protein X-ray crystallography is























structures; (2) complimentarily structured peptides, or
when a peptide was structured with the aid of other
substances, also could trigger the fusion; and (3) a fusion-
active peptide takes a-helix in lipid bilayers, with the helix
axis 30° from the membrane plane [2].
Not all of amphiphilic peptides are active fusogen of
lipid membranes. It is quite apparent that specific amino
acid sequences or compositions must be required. We
have tried to reveal the necessary conditions that are
required for peptides to be active in inducing membrane
fusion from a study of amino acid sequence-modified
peptides starting from the original influenza HA-2
peptede, which is shown below. Sequence modifications
I HA-Peptide GLFGAIAGFIEGGWTGMIDG I
were such as a one residue was substituted by other amino
acid at a time or a group by a group and about 80 peptides
were obtained in this way. In every situation, amphi-
pathic nature of the peptides was conserved since that was
one of the necessary conditions for peptide to interact
with lipid bilayers. Membrane fusion activities of these
peptides were collected, summarized, and evaluated to
yield a structure-activity relationship [3]. Point (one
residue) modifications usually reserved the activity, at
some specific points such as N-terminal, however, the
nature of the substituted residue critically affected the
activity. For example, an introduction of a charged
group at N-terminus abolished the activity while
substitutions with neutral amino acids, either large or
small, hydrophobic or hydrophilic, did not affect the
activity. At the position 14, substitutions with large
hydrophbic residues reserved the activity but small or
charged did not. The place necessary for activity
expression is not localized because those peptides having
amino acid sequences doubled for the N- or C-terminal
half of the original peptide were inactive. Furthermore,
interchange of the N- and C-terminal halves gave a
peptide which was still active. This suggests that a
combination of residues more than half of the original
peptide is critical for the activity. Our present
explanation what properties of amino acid residues are
correlated to the activity of a peptide is following.
Peptides under consideration are considered to be helical
in lipid bilayers. To fuse apposed membranes some
perturbation must be caused by the peptide-lipid
interactions. It is reasonable to assume such interactions
are due to contacts of peptide surface and surrounding
lipid molecules. We considered the surface area of
amino acid residue as most important in the view of
peptide-lipid interactions and, therefore, plotted
calculated surface area of each residue side chain (A2) as
a helical wheel representation (Figure below), where the
outermost numbers showed residue numbers, marked
circles for residues by which substitution afforded fusion-
active peptides, and filled squares for residues to reduce





a residue surface area profile of a peptide called E-5 taken
as a reference). We could notice a remarkable feature
on the picture, namely a small residue was required at
some points for a peptide to be fusion active, or in other
words, constrictions in a surface area profile must be
present somewhere. Our inactive peptides, such as
those having N- or C-terminal half-doubled or having an
optimized amino acid sequence for an amphipathic a-
helix, show uniform or smooth (without constrictions)
surface area profiles. Also we surveyed other fusion
peptide sequences reported for various viruses and could
recognize a similar feature as shown in above figure. As
our acidic peptides become active at pH below 6,
protonations of carboxylate groups are apparently related
to the fusion activity. Presumably the protonation
increases hydrophobicity of the peptides and makes the
peptides deeper inserted inside lipid bilayers. Deeper
insertion of peptides causes a larger amount of
perturbation on the order of lipid bilayer structure,
crossing a critical degree of disorder or perturbation will
trigger fusion between closely apposed membranes.
As an application of fusion-active peptides to other
field of science, Hirata's group have found the presence of
a fusion-active complementary peptide pair significantly
enhanced incorporation of recombinant DNA into cells
by a lipofection method [4].
References
1. Murata M, Sugahara Y, Takahashi Sand Ohnishi S, J.
Biochem., 102, 957-962 (1987).
2. Takahashi S, Matsumoto T and Ishiguro R, to be
submitted.
3. Ishiguro R, Kimura N and Takahashi S, Biochemistry,
32, 9792-9797 (1993).
4. Kamata H, Yagisawa H, Takahashi S and Hirata H,
Nucleic Acids Res., 22, 536-537 (1994).
